Search research articles
Contact Us
Filters
Showing results (101-110 of 329) with videos related to
Page
of 33
Sort By:
Journal of Alzheimer'S Disease : JAD
|
October 15, 2013
Incomplete penetrance of the C9ORF72 hexanucleotide repeat expansions: frequency in a cohort of geriatric non-demented subjects
Daniela Galimberti, Beatrice Arosio, Chiara Fenoglio, et al.
Journal of Neuroinflammation
|
June 8, 2011
Loss of function mutations in the progranulin gene are related to pro-inflammatory cytokine dysregulation in frontotemporal lobar degeneration patients
Paola Bossù, Francesca Salani, Antonella Alberici, et al.
Brain Research
|
March 30, 2010
Loss of epidermal growth factor regulation by cobalamin in multiple sclerosis
Giuseppe Scalabrino, Daniela Galimberti, Elena Mutti, et al.
Neurobiology of Aging
|
November 26, 2005
Serum MCP-1 levels are increased in mild cognitive impairment and mild Alzheimer's disease
Daniela Galimberti, Chiara Fenoglio, Carlo Lovati, et al.
Plos One
|
March 19, 2016
Weight Loss Predicts Progression of Mild Cognitive Impairment to Alzheimer's Disease
Ilaria Cova, Francesca Clerici, Annalia Rossi, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
|
June 26, 2015
Balò's concentric sclerosis: still to be considered as a variant of multiple sclerosis?
Anna M Pietroboni, Andrea Arighi, Milena A De Riz, et al.
Journal of Alzheimer'S Disease : JAD
|
July 24, 2009
The serotonin transporter promoter polymorphic region is not a risk factor for Alzheimer's disease related behavioral disturbances
Diego Albani, Francesca Prato, Mauro Tettamanti, et al.
Journal of Alzheimer'S Disease : JAD
|
September 17, 2016
Growth Arrest Specific 6 Concentration is Increased in the Cerebrospinal Fluid of Patients with Alzheimer's Disease
Pier Paolo Sainaghi, Mattia Bellan, Franco Lombino, et al.
NPJ Parkinson'S Disease
|
December 10, 2020
Cerebrospinal fluid glutamate changes in functional movement disorders
Benedetta Demartini, Roberto William Invernizzi, Laura Campiglio, et al.
Pharmaceuticals (Basel, Switzerland)
|
November 27, 2021
Pharmacological and Epigenetic Regulators of NLRP3 Inflammasome Activation in Alzheimer's Disease
Francesca La Rosa, Roberta Mancuso, Simone Agostini, et al.
Page
of 33
Search research articles
Search
Showing results (101-110 of 329) with videos related to
Sort By:
Page
of 33
Journal of Alzheimer'S Disease : JAD
|
October 15, 2013
Incomplete penetrance of the C9ORF72 hexanucleotide repeat expansions: frequency in a cohort of geriatric non-demented subjects
Daniela Galimberti, Beatrice Arosio, Chiara Fenoglio, et al.
Journal of Neuroinflammation
|
June 8, 2011
Loss of function mutations in the progranulin gene are related to pro-inflammatory cytokine dysregulation in frontotemporal lobar degeneration patients
Paola Bossù, Francesca Salani, Antonella Alberici, et al.
Brain Research
|
March 30, 2010
Loss of epidermal growth factor regulation by cobalamin in multiple sclerosis
Giuseppe Scalabrino, Daniela Galimberti, Elena Mutti, et al.
Neurobiology of Aging
|
November 26, 2005
Serum MCP-1 levels are increased in mild cognitive impairment and mild Alzheimer's disease
Daniela Galimberti, Chiara Fenoglio, Carlo Lovati, et al.
Plos One
|
March 19, 2016
Weight Loss Predicts Progression of Mild Cognitive Impairment to Alzheimer's Disease
Ilaria Cova, Francesca Clerici, Annalia Rossi, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
|
June 26, 2015
Balò's concentric sclerosis: still to be considered as a variant of multiple sclerosis?
Anna M Pietroboni, Andrea Arighi, Milena A De Riz, et al.
Journal of Alzheimer'S Disease : JAD
|
July 24, 2009
The serotonin transporter promoter polymorphic region is not a risk factor for Alzheimer's disease related behavioral disturbances
Diego Albani, Francesca Prato, Mauro Tettamanti, et al.
Journal of Alzheimer'S Disease : JAD
|
September 17, 2016
Growth Arrest Specific 6 Concentration is Increased in the Cerebrospinal Fluid of Patients with Alzheimer's Disease
Pier Paolo Sainaghi, Mattia Bellan, Franco Lombino, et al.
NPJ Parkinson'S Disease
|
December 10, 2020
Cerebrospinal fluid glutamate changes in functional movement disorders
Benedetta Demartini, Roberto William Invernizzi, Laura Campiglio, et al.
Pharmaceuticals (Basel, Switzerland)
|
November 27, 2021
Pharmacological and Epigenetic Regulators of NLRP3 Inflammasome Activation in Alzheimer's Disease
Francesca La Rosa, Roberta Mancuso, Simone Agostini, et al.
Page
of 33